Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

Publication date: Available online 10 July 2021Source: The Lancet Respiratory MedicineAuthor(s): Sarah Diver, Latifa Khalfaoui, Claire Emson, Sally E Wenzel, Andrew Menzies-Gow, Michael E Wechsler, James Johnston, Nestor Molfino, Jane R Parnes, Ayman Megally, Gene Colice, Christopher E Brightling
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research